Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC
-
Published:2024-04
Issue:4
Volume:5
Page:100656
-
ISSN:2666-3643
-
Container-title:JTO Clinical and Research Reports
-
language:en
-
Short-container-title:JTO Clinical and Research Reports
Author:
Gulikers Judith L.ORCID,
Veerman G.D. Marijn,
Jebbink Merel,
Kruithof Paul D.,
Steendam Christi M.J.,
Boosman René J.,
Mathijssen Ron H.J.,
Tjan-Heijnen Vivianne C.G.,
Driessen Johanna H.M.,
Dursun Safiye,
Smit Egbert F.,
Dingemans Anne-Marie C.,
van Geel Robin M.J.M.,
Croes Sander,
Hendriks Lizza E.L.ORCID